Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

A cannabis plant is shown in southwest Quebec on Oct. 8, 201


Canada's largest cannabis-related exchange-traded fund is adding 10 new marijuana stocks to its portfolio.

Horizons ETFs Management (Canada) Inc. announced, as part of its latest quarterly rebalancing, the shares of 10 new companies were added to the portfolio of Toronto-listed Horizons Marijuana Life Sciences Index ETF (HMMJ).

Medical cannaboid provider Nuuvera Inc. will hold the largest weighting of the new firms with 1.7 per cent, with the remaining companies holding approximately 1 per cent or less of the index. Licensed marijuana producer Aphria Inc. announced an agreement in January to buy medical cannabis firm Nuuvera in a cash-and-stock deal that it says values the company at $826-million.

Story continues below advertisement

British-Columbia based Hiku Brands Co. Ltd. has also been added to the index, a retail cannabis outlet recently created with the merger between DOJA Cannabis Company Ltd. and TS Brandco Holdings Inc.

With a management fee of 0.75 per cent, the Horizons index aims to replicate the 47-stock North American Marijuana Index. The index is designed to provide exposure to the performance of a basket of North American publicly listed life-sciences companies with significant business activities in the marijuana industry and may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses related to the marijuana industry.

Of the 47, the Horizons index now tracks 37 of them – a number that has more than doubled since the fund's inception. Last December, Steven Hawkins, president and co-chief executive officer of Horizons ETFs, said he expected to add two to five new companies to the ETF every quarter for the next year, as new companies emerge in the cannabis sector.

The 10 new companies include:

  • Abattis Bioceuticals Corp. (ATT)
  • Beleave Inc. (BE)
  • HIKU Brands Co. Ltd. (HIKU)
  • Isodiol International Inc. (ISOL)
  • National Access Cannabis Corp. (NAC)
  • Neptune Technologies and Bioressources Inc. (NEPT)
  • Nuuvera Inc. (NUU)
  • Tetra Bio-Pharma Inc. (TBP)
  • Terrascend Corp. (TER)
  • THC Biomed International Ltd. (THC)
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to
Comments are closed

We have closed comments on this story for legal reasons or for abuse. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies